DDMAC Warns Allergan for Misleading Lumigan Promotion

Drug Industry Daily
KEYWORDS FDA / Warning
A A

The FDA’s advertising division has issued a warning letter to Allergan for disseminating misleading promotional materials for ocular treatment Lumigan.

To View This Article:

Login

Subscribe To Drug Industry Daily